1
Total investments
1
Early stage
0
Mid stage
0
Late stage
4y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Head, Funding and Investor Strategy
Dec 2022
Inocras is a bioinformatics-led company redefining precision health through whole genome data and proprietary analytics. Our oncology and rare disease platforms integrate comprehensive whole genome data with advanced automation to deliver curated and actionable insights at scale. These capabilities deliver curated, actionable insights that accelerate discovery and diagnostics to improve patient care, bringing a real-world impact. We operate a CLIA/CAP-certified laboratory and partners with leading hospitals, pharmaceutical companies, and research institutions worldwide.
Experience · 1 entries
All (1)
Investments (1)
2022
Head, Funding and Investor Strategy
Dec 2022
Inocras is a bioinformatics-led company redefining precision health through whole genome data and proprietary analytics. Our oncology and rare disease platforms integrate comprehensive whole genome data with advanced automation to deliver curated and actionable insights at scale. These capabilities deliver curated, actionable insights that accelerate discovery and diagnostics to improve patient care, bringing a real-world impact. We operate a CLIA/CAP-certified laboratory and partners with leading hospitals, pharmaceutical companies, and research institutions worldwide.